The Antipsychotics Market Insight & Analysis 2008 Topics: CNS/Neurology, Behavioral Health
|
Offices of Mental Health Practitioners (except Physicians) in the US - Industry Risk Rating Report Topics: Physicians' Offices, Behavioral Health
Regions: United States
|
Outpatient Mental Health and Substance Abuse Centers in the US - Industry Risk Rating Report Topics: Services, Behavioral Health
Regions: United States
|
Residential Mental Health and Substance Abuse Facilities in the US - Industry Risk Rating Report Topics: Facilities, Behavioral Health
Regions: United States
|
Psychiatric and Substance Abuse Hospitals in the US - Industry Risk Rating Report Topics: Hospitals & Clinics, Behavioral Health
Regions: United States
|
Plimsoll Portfolio Analysis - Mental Health Centres (UK) Topics: Facilities Company Reports, Behavioral Health
|
Pipeline Insight: Substance Dependence - Part II: Alcohol Topics: Drug Discovery, Behavioral Health
|
Outpatient Mental Health and Substance Abuse Centers in the US - Industry Market Research Report Topics: Facilities, Behavioral Health
|
Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster Topics: Pharmaceuticals, Over-the-Counter Drugs, Prescription Drugs, Behavioral Health, Smoking Cessation
Regions: Global
|
Commercial Insight: Depression - Atypical Lifecycle Management Strategy Rejuvenates Depression Market Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Conference Documentation: Depression & Anxiety Topics: Drug Discovery, Behavioral Health
|
The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System Topics: Obesity, Pain, Alzheimer's Disease, Medical Devices, CNS/Neurology, Behavioral Health
|
Offices of Mental Health Practitioners (except Physicians) in the US - Industry Market Research Report Topics: Facilities, Behavioral Health
Regions: United States
|
Psychiatric and Substance Abuse Hospitals in the US - Industry Market Research Report Topics: Hospitals & Clinics, Behavioral Health
|
Smoking Cessation and Addiction Treatments: A World Market Analysis Topics: Wellness/Prevention Programs, Pharmaceuticals, Prescription Drugs, Respiratory/Pulmonary, Behavioral Health, Smoking Cessation
Regions: Global
|
Residential Mental Health and Substance Abuse Facilities in the US - Industry Market Research Report Topics: Facilities, Behavioral Health
Regions: United States
|
Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market Topics: CNS/Neurology, Behavioral Health
Regions: United States
|
Pipeline Insight: Depression - Novel drugs to grow third-line market Topics: CNS/Neurology, Behavioral Health
|
Psychiatric & Other Specialist Hospital Services in Indonesia Topics: Facilities, Behavioral Health
Regions: Indonesia
|
Disease and Therapy Review: Bipolar Disorder Topics: CNS/Neurology, Behavioral Health
Regions: Global
|
Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market Topics: Research & Development, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: Global
|
Disease and Therapy Review: Major Depressive Disorder Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Atypical Antipsychotics: Life-Cycle Management and Future Trends Topics: Pharmaceuticals, Prescription Drugs, CNS/Neurology, Behavioral Health
|
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD) Chapter Topics: Prescription Drugs, Drug Discovery, CNS/Neurology, Behavioral Health
|
Anti-addiction Therapies, 2006-2011 - The Pharmaceutical Industry’s Next Viagra? Topics: Pharmaceuticals, Research & Development, CNS/Neurology, Behavioral Health, Smoking Cessation
|
The 2007-2012 Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants in the United States Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Antidepressant Agents in the United States Topics: Prescription Drugs, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Antidepressant Pharmaceuticals in the United States Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States
|
The 2007-2012 Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives in the United States Topics: Prescription Drugs, Behavioral Health
|
Worldwide Psychotherapeutic Drug Market Topics: Pharmaceuticals, Behavioral Health
Regions: Global
|
Residential Mental Health and Substance Abuse Facilities in the US Topics: Facilities, Behavioral Health
Regions: United States
|
Pipeline Insight: Bipolar Disorder - New Treatments for Bipolar Depression Set to Drive Near-term Growth Topics: Research & Development, Prescription Drugs, CNS/Neurology, Behavioral Health
|
Conference Documentation: Depression & Anxiety Topics: Prescription Drugs, Drug Discovery, Behavioral Health
|
European Antidepressants Markets Topics: Behavioral Health
Regions: Europe
|
The 2007-2012 World Outlook for Psychotherapeutic Antidepressant Agents Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
The 2007-2012 World Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Stakeholder Insight: Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need? Topics: Prescription Drugs, Behavioral Health
|
Pipeline Insight: Anxiety Disorders - A Decade of Declining Revenues Topics: Drug Discovery, Behavioral Health
|
Residential Mental Retardation Facilities in the US Topics: Behavioral Health
Regions: United States
|
Sleeper Diseases: Forecast and Assessment of Neglected Disease Market Opportunities Topics: Diseases & Conditions, Respiratory/Pulmonary, Behavioral Health
|
Antidepressants Topics: Prescription Drugs, Behavioral Health
Regions: Global
|
Residential Mental Retardation Facilities in the US - Industry Market Research Report Topics: Facilities, Behavioral Health
Regions: United States
|
Impact of Generics on the Antidepressant Market Topics: Pharmaceuticals, Generics Drugs, Prescription Drugs, Behavioral Health
|
Residential Mental Health and Substance Abuse Facilities in the US Topics: Facilities, Behavioral Health
Regions: United States
|
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactivity Disorder Market Topics: Behavioral Health
|
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012 Topics: Prescription Drugs, CNS/Neurology, Behavioral Health
Regions: United States, Global
|
Residential Mental Retardation Facilities in the US Topics: Facilities, Behavioral Health
Regions: United States
|
The World Market for Antidepressants, 2006 Topics: Prescription Drugs, Behavioral Health
|
Emotional and Behavioral Disorders in Children and Adolescents Topics: Children, Teens (13-19), Behavioral Health
|
Commercial Insight: ADHD - Strattera Reigns Supreme as Branded Stimulants Slump Topics: Behavioral Health
|